Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 11.1% | 12.5% | 14.1% | 11.2% | 20.5% | 11.9% | 11.2% | 11.3% | 11.2% | 10.5% | 10.8% | 10.3% | 14.9% | 13.6% | 16.0% | 14.1% | 17.6% | 16.6% | 15.8% | 15.2% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 13.0%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Elevance Health Inc. have been 15.8% over the past three years, and 16.4% over the past five years.
As of today, Elevance Health Inc.'s Return on Equity (ROE) is 13.0%, which is higher than industry median of 7.1%. It indicates that Elevance Health Inc.'s Return on Equity (ROE) is Good.